David Shaywitz

AEI Adjunct Scholar
Theravance, Inc.

Dr. Shaywitz trained in internal medicine and endocrinology at MGH, and conducted his post-doctoral research in the Melton lab at Harvard. He gained experience in early clinical drug development in the Department of Experimental Medicine at Merck, then joined the Boston Consulting Group’s Healthcare and Corporate Development practices, where he focused on strategy and organizational design. He is currently Director of Strategic and Commercial Planning at Theravance, a publicly-held drug development company in South San Francisco. He recently wrote Tech Tonics: Can Passionate Entreprenuers Heal Healthcare With Technology? 


Ph.D., Biology, M.I.T.

M.D., Health Sciences & Technology Program, Harvard Medical School/M.I.T.

A.B., summa cum laude, Biochemistry, Harvard College